Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
If Shank3 mutations are found to affect anesthetic sensitivity in patients with ASD, better communication and stricter monitoring of anesthetic depth may be necessary.
|
27856360 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Hoxb8 mutants also exhibit hyperanxiety and social behavioral deficits similar to mice with neuronal mutations in Sapap3, Slitrk5 and Shank3, reported models of OCD and autism spectrum disorders (ASDs).
|
28948967 |
2018 |
Autism Spectrum Disorders
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Our work provides new data on the link between postnatal exposure to ambient PM2.5 and the onset of ASD-like symptoms in human beings, and the increased inflammatory response and abnormalities in Shank3 expression in the brain may contribute to the mechanisms of PM2.5 exposure-induced ASD.
|
29121345 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Whether the impairments in associative learning observed in ASD relate to SHANK3 insufficiency restricted to the reward system is still an open question.
|
30364266 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder.
|
28753255 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Given the zinc sensitivity of young neurons and its dependence on Shank2 and Shank3, genetic mutations and/or environmental insults during early development could impair synaptic maturation and circuit formation that underlie ASD etiology.
|
30524232 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this study, we used mutant/knock-out mice of Shank2 (<i>Shank2</i><sup>-/-</sup>), Shank3 (<i>Shank3</i>αβ<sup>-/-</sup>), and Cntn4 (<i>Cntn4</i><sup>-/-</sup>) as ASD-models to explore whether these mice share a molecular signature in glutamatergic and GABAergic synaptic transmission in ASD-related brain regions.
|
29970989 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Shank3 is an excitatory postsynaptic scaffolding protein implicated in multiple brain disorders, including autism spectrum disorders (ASD) and Phelan-McDermid syndrome (PMS).
|
30356810 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We generated induced pluripotent stem cells (iPSCs) from control individuals and from human donors with ASD carrying microdeletions of SHANK3.
|
28948968 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
De novo mutations (DNMs) of SHANK3 were subsequently identified in patients with several neurodevelopmental disorders, including autism spectrum disorders (ASDs), schizophrenia (SCZ), a Rett syndrome-like phenotype, and intellectual disability (ID).
|
30537371 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Environmental enrichment has minimal effects on behavior in the Shank3 complete knockout model of autism spectrum disorder.
|
30317697 |
2018 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Our study did not identify a significant association of SHANK3 SNPs with ASD in the Northeast Han Chinese population.
|
29408620 |
2018 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations/deletions in the SHANK3 gene are associated with autism spectrum disorders and intellectual disability.
|
27492494 |
2017 |
Autism Spectrum Disorders
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
In this issue of the JCI, Wang and coworkers show that glutamatergic synaptic transmission onto striatal projection neurons is weakened in mutant mice lacking the SH3 and multiple ankyrin repeat domains 3 (SHANK3B) scaffolding protein, defective expression of which has been implicated in ASDs.
|
28414299 |
2017 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated the molecular mechanisms associated with the ASD-like behaviors observed in Shank3Δ11<sup>-/-</sup> mice, in which exon 11 has been deleted.
|
27021819 |
2017 |
Autism Spectrum Disorders
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Deletions and point mutations in SHANK3 cause Phelan-McDermid Syndrome (PMS), and have also been implicated in autism spectrum disorder (ASD) and intellectual disabilities, leading to the hypothesis that reduced SHANK3 expression impairs basic brain functions that are important for social communication and cognition.
|
27189882 |
2017 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Together with these findings, we have identified maternal genetic effects not previously identified in ASD at a locus in SHANK3 on chromosome 22 and a locus in WBSCR17 on chromosome 7 (associated with Williams syndrome).
|
27876814 |
2017 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Several large-scale genomic studies have supported an association between cases of autism spectrum disorder and mutations in the genes SH3 and multiple ankyrin repeat domains protein 1 (SHANK1), SHANK2 and SHANK3, which encode a family of postsynaptic scaffolding proteins that are present at glutamatergic synapses in the CNS.
|
28179641 |
2017 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this "<i>Perspectives</i>" article, we review and comment on current advances in Shank3 research and include some original data that show common Shank3 deficits in a number of seemingly unrelated human neurological disorders that include sporadic Alzheimer's disease (AD), autism spectrum disorder (ASD), bipolar disorder (BD), Phelan-McDermid syndrome (PMS; 22q13.3 deletion syndrome), and schizophrenia (SZ).
|
29321759 |
2017 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
An evaluation of the behavioural phenotype of PMS and the prevalence and phenomenology of ASD is warranted, particularly given the causal involvement of the SHANK3 gene in the aetiology of PMS.
|
29126394 |
2017 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our data support that recurrent genomic rearrangements at 22q13.3 are part of the genetic landscape of ASD in our patients and changes in SHANK3 dosage are associated with neurodevelopmental disorders.
|
27846046 |
2017 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have shown that Autism spectrum disorder is a result of mutations of the main SHANK3 isoforms, which may be due to deficit in excitatory synaptic transmission and plasticity.
|
27592227 |
2017 |
Autism Spectrum Disorders
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The E183V mutation also reduces CaMKIIα binding to established ASD-linked proteins, such as Shank3 and subunits of l-type calcium channels and NMDA receptors, and increases CaMKIIα turnover in intact cells.
|
28130356 |
2017 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
Recent studies have strongly implicated postsynaptic scaffolding proteins such as SAPAP3 or Shank3 in the pathogenesis of various mood disorders, including autism spectrum disorder, bipolar disorder (BD), and obsessive-compulsive disorders.
|
27530683 |
2016 |
Autism Spectrum Disorders
|
0.700 |
Biomarker
|
disease |
BEFREE |
These findings show that deficiency of Shank3 can impair mGluR5-Homer scaffolding, resulting in cortico-striatal circuit abnormalities that underlie deficits in learning and ASD-like behaviours.
|
27161151 |
2016 |